Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index

Am J Kidney Dis. 2009 Jun;53(6):993-1001. doi: 10.1053/j.ajkd.2008.12.043. Epub 2009 Apr 25.

Abstract

Background: Adiposity is associated with cystatin C. Cystatin C-based glomerular filtration rate (GFR) equations may result in overestimation of chronic kidney disease (CKD) prevalence at greater body mass index (BMI) levels.

Study design: Cross-sectional.

Setting & participants: 6,709 US adult Third National Health and Nutrition Examination Survey participants.

Factor: BMI.

Outcome: Absolute percentage of difference in prevalence of stage 3 or 4 CKD between creatinine- and cystatin C-based estimating equations by level of BMI.

Measurements: Normal weight, overweight, and obesity were defined as BMI of 18.5 to less than 25.0, 25 to less than 30.0, and 30 kg/m(2) or greater, respectively. Stage 3 or 4 CKD (estimated glomerular filtration rate [eGFR], 15 to 59 mL/min/1.73 m(2)) was defined using the 4-variable creatinine-based Modification of Diet in Renal Disease Study equation (eGFR(MDRD)); cystatin C level, age, sex, and race equation (eGFR(CysC,age,sex,race)); cystatin C-only equation (eGFR(CysC)); cystatin C level of 1.12 mg/L or greater (increased cystatin C); and an equation incorporating serum creatinine level, cystatin C level, age, sex, and race (eGFR(Cr,CysC,age,sex,race)).

Results: Differences in stage 3 or 4 CKD prevalence estimates between eGFR(CysC,age,sex,race), eGFR(CysC), and increased cystatin C, separately, and eGFR(MDRD) were greater at higher BMI levels. Specifically, compared with estimates derived using eGFR(MDRD) for normal-weight, overweight, and obese participants, estimated prevalences of stage 3 or 4 CKD were 2.1%, 3.0%, and 6.5% greater when estimated by using eGFR(CysC,age,sex,race) (P trend = 0.005); 0.1%, 0.6%, and 2.2% greater for eGFR(CysC) (P trend = 0.03); 2.9%, 5.2%, and 9.5% greater for increased cystatin C (P trend < 0.001); and -0.1%, -0.4%, and 0.0% greater for eGFR(Cr,CysC,age,sex,race), respectively (P trend = 0.7).

Limitations: No gold-standard measure of GFR was available.

Conclusions: BMI may influence the estimated prevalence of stage 3 or 4 CKD when cystatin C-based equations are used.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Body Mass Index*
  • Child
  • Creatinine / blood*
  • Cross-Sectional Studies
  • Cystatin C / blood*
  • Female
  • Glomerular Filtration Rate / physiology
  • Humans
  • Kidney Diseases / blood*
  • Kidney Diseases / epidemiology
  • Kidney Diseases / physiopathology*
  • Kidney Function Tests / methods
  • Kidney Function Tests / statistics & numerical data
  • Male
  • Middle Aged
  • Models, Statistical*
  • Prevalence
  • Young Adult

Substances

  • Cystatin C
  • Creatinine